| 今开：2.5 | 昨收：2.5 |
| 最高：2.61 | 最低：2.4601 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：3319035.0 |
OpGen(OPGN)04-09 04:15
$OpGen(OPGN)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001829126-24-002304 Act: 34 Size: 32 KB 网页链接查看全文
OpGen(OPGN)04-26 04:45
$OpGen(OPGN)$ 8-K Current report, items 4.01 and 9.01 Accession Number: 0001829126-24-002784 Act: 34 Size: 264 KB 网页链接查看全文
OpGen(OPGN)06-04 05:05
$OpGen(OPGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001829126-24-003930 Act: 34 Size: 9 MB 网页链接查看全文
OpGen(OPGN)03-29 20:05
$OpGen(OPGN)$ NT 10-K Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 Accession Number: 0001829126-24-002011 Act: 34 Size: 21 KB 网页链接查看全文
OpGen(OPGN)03-30 02:45
$OpGen(OPGN)$ 8-K Current report, items 1.01, 3.02, 3.03, 5.02, 5.03, 8.01, and 9.01 Accession Number: 0001829126-24-002035 Act: 34 Size: 5 MB 网页链接查看全文
OpGen(OPGN)04-09 04:15
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-24-000813 Size: 6 KB 网页链接查看全文
OpGen(OPGN)04-17 04:25
$OpGen(OPGN)$ PRE 14A Other preliminary proxy statements Accession Number: 0001829126-24-002570 Act: 34 Size: 341 KB 网页链接查看全文
OpGen(OPGN)04-15 21:15
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-24-000834 Size: 4 KB 网页链接查看全文
OpGen(OPGN)04-13 05:05
$OpGen(OPGN)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0000921895-24-000830 Size: 4 KB 网页链接查看全文
OpGen(OPGN)06-12 04:25
$OpGen(OPGN)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001829126-24-004077 Act: 34 Size: 203 KB 网页链接查看全文
牛股小红书2022-04-07 14:13
诺华的Sandoz将其与$OpGen(OPGN)$ 的子公司Ares Genetics的战略合作延长至2025年1月31日，旨在推动对抗耐药性的尖端数字解决方案。
两家公司表示，在合作的初始阶段，Ares开发了一个数字抗感染平台，将微生物学实验室实践与先进的生物信息学和人工智能方法相结合，以帮助识别有效的抗菌化合物...查看全文
蹊之美股生物医药2021-10-08 00:15
作者：林出
微信公众号：蹊之美股生物医药 / CaesarBiotech
Gainers:
Voyager Therapeutics (NASDAQ:VYGR) +56%
Acer Therapeutics (NASDAQ:ACER) +16%
Molecular Partners (NASDAQ:MOLN) +10%
Rafael (NYSE:RFL) +6%
Arcturus Therapeutics (NASDA...查看全文
东哥_Singapore2021-03-08 23:42
$Jaguar Health(JAGX)$ 给力点啊，速度冲2.5！刚才在2.9的OPGN跟1.85的你之间，最后选的你！不要让我失望啊！OPGN已经爆拉了！！！$OpGen(OPGN)$查看全文
$OpGen(OPGN)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001829126-24-004077 Act: 34 Size: 203 KB 网页链接
$OpGen(OPGN)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001829126-24-003930 Act: 34 Size: 9 MB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001829126-24-003926 Act: 34 Size: 202 KB 网页链接
$OpGen(OPGN)$ 8-K/A [Amend] Current report, items 5.02 and 9.01 Accession Number: 0001829126-24-003876 Act: 34 Size: 218 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 3.01 and 9.01 Accession Number: 0001829126-24-003748 Act: 34 Size: 223 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 1.01, 3.03, 5.03, 8.01, and 9.01 Accession Number: 0001829126-24-003657 Act: 34 Size: 329 KB 网页链接
$OpGen(OPGN)$ NT 10-Q Notification of inability to timely file Form 10-Q or 10-QSB Accession Number: 0001829126-24-003485 Act: 34 Size: 43 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 3.03, 5.03, 5.07, and 9.01 Accession Number: 0001829126-24-003340 Act: 34 Size: 335 KB 网页链接
$OpGen(OPGN)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001829126-24-002907 Act: 34 Size: 299 KB 网页链接
$OpGen(OPGN)$ DEF 14A Other definitive proxy statements Accession Number: 0001829126-24-002814 Act: 34 Size: 457 KB 网页链接